Abstract

Biomarkers are measurable indicators that can be used to diagnose diseases or monitor their progression. In vitreoretinal conditions, biomarkers can be found in various structures of the eye, including the retina, vitreous, and choroid.One of the most commonly used biomarkers in vitreoretinal conditions is visual acuity, which is a measure of how well a person can see. Other biomarkers include imaging techniques, such as optical coherence tomography (OCT) and fundus photography, which can provide detailed images of the retina and vitreous.In addition to structural biomarkers, there are also functional biomarkers that can be used to evaluate visual function, such as contrast sensitivity and visual field testing. These measures are often used to monitor the progression of diseases such as macular degeneration and diabetic retinopathy.Recent advances in biomarker research have led to the discovery of new markers for vitreoretinal conditions, including genetic markers, inflammatory markers, and metabolic markers. These markers may provide new insights into the underlying mechanisms of disease and may help to identify new therapeutic targets.Overall, biomarkers are an important tool in vitreoretinal conditions for the diagnosis, monitoring, and management of a wide range of ocular diseases. They may also help to improve our understanding of these conditions and facilitate the development of new therapies.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call